Information:
Fel:
ID
20223
Beskrivning
Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irinotecan; ODM derived from: https://clinicaltrials.gov/show/NCT00507143
Länk
https://clinicaltrials.gov/show/NCT00507143
Nyckelord
Versioner (1)
- 2017-02-14 2017-02-14 -
Uppladdad den
14 februari 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Colorectal Neoplasms NCT00507143
Eligibility Colorectal Neoplasms NCT00507143
- StudyEvent: Eligibility
Similar models
Eligibility Colorectal Neoplasms NCT00507143
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Colorectal Carcinoma unresectable | Colorectal cancer metastatic
Item
histologically or cytologically diagnosed unresectable or metastatic colorectal cancer
boolean
C0009402 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C0948380 (UMLS CUI [2])
C1519810 (UMLS CUI [1,2])
C0948380 (UMLS CUI [2])
ECOG performance status
Item
performance status of 0, 1 and 2 on the ecog criteria
boolean
C1520224 (UMLS CUI [1])
Measurable Disease | Non-Target Lesion
Item
disease status must be that of measurable disease as defined by recist criteria (for genotype-pd study only) only non-target lesions are allowed for pk study
boolean
C1513041 (UMLS CUI [1])
C2986547 (UMLS CUI [2])
C2986547 (UMLS CUI [2])
Chemotherapy | Therapeutic radiology procedure Target Lesion | Immunotherapy | Adjuvant Chemotherapy Completed | fluoropyrimidine
Item
no previous chemotherapy, radiotherapy on the target lesion, immunotherapy; adjuvant chemotherapy with fluoropyrimidines completed at least 6 months ago is allowed (for genotype-pd study only) previously treated patients are allowed for pk study
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2,1])
C2986546 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3])
C0085533 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C0596581 (UMLS CUI [5])
C1522449 (UMLS CUI [2,1])
C2986546 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3])
C0085533 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C0596581 (UMLS CUI [5])
Life Expectancy
Item
life expectancy of more than 3 months (for genotype-pd study only)
boolean
C0023671 (UMLS CUI [1])
Organ function Major
Item
adequate major organ functions
boolean
C0678852 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,2])
Compliance behavior | Follow-up Adequate
Item
compliant patient who can be followed-up adequately
boolean
C1321605 (UMLS CUI [1])
C3274571 (UMLS CUI [2,1])
C0205411 (UMLS CUI [2,2])
C3274571 (UMLS CUI [2,1])
C0205411 (UMLS CUI [2,2])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Communicable Disease | Communicable Disease Uncontrolled
Item
active or uncontrolled infection
boolean
C0009450 (UMLS CUI [1])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Pregnancy | Breast Feeding
Item
pregnant or breast-feeding women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Systemic disease | Cardiovascular Disease | Patient intolerant Systemic Chemotherapy
Item
patients with systemic disease, especially cardiovascular disease, who cannot tolerate systemic chemotherapy
boolean
C0442893 (UMLS CUI [1])
C0007222 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C0231200 (UMLS CUI [3,2])
C1883256 (UMLS CUI [3,3])
C0007222 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C0231200 (UMLS CUI [3,2])
C1883256 (UMLS CUI [3,3])
Metastatic malignant neoplasm to brain
Item
patients with brain metastasis (for genotype-pd study only)
boolean
C0220650 (UMLS CUI [1])
Therapeutic radiology procedure
Item
patients treated with radiotherapy within 2 weeks (for genotype-pd study only)
boolean
C1522449 (UMLS CUI [1])